EU-LIFE announced its reaction to the European Commission´s proposal for Horizon Europe, the next Framework Programme for Research and Innovation (FP9) that will run from 2021 to 2027. The key points are as follows:
- EU-LIFE urges the European Parliament and the EU Council to push for a stronger Horizon Europe by raising its budget as recommended by several reports.
- EU-LIFE encourages Horizon Europe to expand the extremely successful programmes it has initiated, namely the ERC grant system and Marie Skłodowska-Curie Actions, in addition to collaborative projects that address technological and environmental challenges facing our society today. These actions attract and foster the best and brightest minds, and encourage ground-breaking research that will ensure Europe’s leadership in technological and biomedical innovation in the future.
- EU-LIFE supports the on calling for: increased total budget of Horizon Europe, a review of budget allocation, centre the Programme’s pillars on the realisation of the European Research Area, better integration among research, innovation and education.
- EU-LIFE supports the announced ‘mission’ actions and recommends that researchers and innovators are involved in identifying and managing missions.
EU-LIFE’s full statement is available on:
“We believe that the negotiations starting now will raise the potential of Horizon Europe in addressing important challenges faced by European citizens and the world,” says Marta Agostinho, Coordinator of EU-LIFE. “We urge the European Parliament and the European Council to go a step further and raise the priority of Research & Innovation in EU MFF, namely by providing Horizon Europe with a 150 Billion Euro budget.”
“Research & Innovation is a strong pillar under the EU ideal. Few other fields illustrate so clearly the added value of the European Union. The European Research Council, for example, has become one of the most acclaimed success stories of Europe. We must secure this legacy and invest more in its proven contribution to a better world,” says Genevieve Almouzni, Chair of EU-LIFE and Scientific Director of Institut Curie, France.
EU-LIFE is an alliance of research centres whose mission is to support and strengthen European research excellence (www.eu-life.eu). EU-LIFE members are leading research institutes in their countries and internationally renowned for producing excellent research, widely transferring knowledge and nurturing talent.
Centro de Regulación Genómica (CRG, Spanien) | Central European Institute of Technology (CEITEC, Tschechische Republik) | Istituto Europeo di Oncologia (IEO, Italien) | Friedrich Miescher Institute for Biomedical Research (FMI, Schweiz) | Institut Curie (Frankreich) | Institute for Molecular Medicine Finland (FIMM, Finnland) | Instituto Gulbenkian de Ciência (IGC, Portugal) | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC, Deutschland) | Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften (CeMM, Österreich) | Nederlands Kanker Instituut (NKI, Niederlande) | Biotech Research & Innovation Centre der Kopenhagener Universität (BRIC, Dänemark) | The Babraham Institute (Babraham, Vereinigtes Königreich) | Vlaams Instituut voor Biotechnologie (VIB, Belgien)
About the Horizon Europe (Framework Programme 9)
Horizon Europe, the European Research Programme 9, will run from January 2021 to the end of 2027. It will replace the current Horizon 2020 programme. The European Commission (EC) published its programme proposal on the 8th June 2018 and announced a €94.1 billion research budget. A final Horizon Europe programme will be reached upon negotiations among the EC, the European parliament and the European Council.
For more information
Marta Agostinho, PhD